Holen Sie sich die Stockscreener-App
1.78
0.00%
0.00
Handel nachbörslich:
1.80
0.02
+1.12%
Schlusskurs vom Vortag:
$1.78
Offen:
$1.78
24-Stunden-Volumen:
966.49K
Relative Volume:
0.69
Marktkapitalisierung:
$151.29M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-59.69M
KGV:
-1.2806
EPS:
-1.39
Netto-Cashflow:
$-46.54M
1W Leistung:
-1.66%
1M Leistung:
+19.46%
6M Leistung:
+8.54%
1J Leistung:
+19.46%
1-Tages-Spanne:
$1.75
$1.81
1-Wochen-Bereich:
$1.75
$1.905
52-Wochen-Spanne:
$0.6254
$2.75
Milestone Pharmaceuticals Inc Stock (MIST) Company Profile
Firmenname
Milestone Pharmaceuticals Inc
Sektor
Branche
Telefon
(514) 336-0444
Adresse
1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420, MONTREAL, QC
Vergleichen Sie MIST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MIST
Milestone Pharmaceuticals Inc
|
1.78 | 156.33M | 0 | -59.69M | -46.54M | -1.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Milestone Pharmaceuticals Inc Stock (MIST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-05 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-08-22 | Eingeleitet | Rodman & Renshaw | Buy |
| 2023-06-20 | Herabstufung | Jefferies | Buy → Hold |
| 2022-04-22 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-03-05 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-07-29 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-07-24 | Hochstufung | Jefferies | Hold → Buy |
| 2020-03-25 | Herabstufung | Jefferies | Buy → Hold |
| 2020-03-24 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-03-24 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-06-04 | Eingeleitet | Oppenheimer | Outperform |
| 2019-06-03 | Eingeleitet | Cowen | Outperform |
| 2019-06-03 | Eingeleitet | Jefferies | Buy |
| 2019-06-03 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Milestone Pharmaceuticals Inc Aktie (MIST) Neueste Nachrichten
Growth Recap: Is Milestone Pharmaceuticals Inc. stock influenced by commodity prices2025 Earnings Impact & Stepwise Trade Signal Guides - khodrobank.com
Visual trend scoring systems applied to Milestone Pharmaceuticals Inc.Portfolio Update Report & Weekly High Potential Stock Alerts - Newser
How to escape a deep drawdown in Milestone Pharmaceuticals Inc.Jobs Report & Growth Oriented Trading Recommendations - Newser
Why Milestone Pharmaceuticals Inc. is moving todayNew Guidance & Real-Time Market Trend Scan - Newser
Measuring Milestone Pharmaceuticals Inc.’s beta against major indicesForecast Cut & AI Forecast for Swing Trade Picks - Newser
What recovery options are there for Milestone Pharmaceuticals Inc.Recession Risk & Daily Profit Maximizing Tips - Newser
Tools to assess Milestone Pharmaceuticals Inc.’s risk profile2025 Momentum Check & Daily Price Action Insights - Newser
Visual analytics tools that track Milestone Pharmaceuticals Inc. performanceTrade Performance Summary & Community Verified Watchlist Alerts - Newser
Relative strength of Milestone Pharmaceuticals Inc. in sector analysis2025 Macro Impact & Step-by-Step Trade Execution Guides - Newser
Has Milestone Pharmaceuticals Inc. found a price floorJuly 2025 Trade Ideas & AI Enhanced Execution Alerts - Newser
Historical volatility pattern of Milestone Pharmaceuticals Inc. visualizedEarnings Recap Summary & Daily Profit Maximizing Trade Tips - Newser
Can technical indicators confirm Milestone Pharmaceuticals Inc.’s reversal2025 Earnings Impact & Weekly High Potential Stock Alerts - Newser
Live market analysis of Milestone Pharmaceuticals Inc.Gold Moves & Safe Capital Allocation Plans - Newser
Short interest data insights for Milestone Pharmaceuticals Inc.2025 Technical Overview & Safe Entry Trade Signal Reports - Newser
Is Milestone Pharmaceuticals Inc. still worth holding after the dipJuly 2025 PostEarnings & Short-Term Swing Trade Alerts - Newser
How liquid is Milestone Pharmaceuticals Inc. stock2025 Earnings Impact & Daily Chart Pattern Signals - khodrobank.com
ANI Pharmaceuticals, Inc. (ANIP) Hits Milestone with Cortrophin Gel Prefilled Syringe Launch - Yahoo Finance
Is Milestone Pharmaceuticals Inc. a momentum stockOil Prices & Comprehensive Market Scan Insights - khodrobank.com
Can machine learning forecast Milestone Pharmaceuticals Inc. recoveryJuly 2025 Pullbacks & Low Volatility Stock Suggestions - Newser
What’s the profit margin of Milestone Pharmaceuticals Inc.July 2025 Summary & Long-Term Growth Plans - khodrobank.com
Is Milestone Pharmaceuticals Inc. stock showing strong momentum2025 Winners & Losers & Risk Adjusted Swing Trade Ideas - khodrobank.com
Milestone Pharmaceuticals Inc. stock chart pattern explained2025 Key Lessons & Capital Efficiency Focused Strategies - Newser
Why Milestone Pharmaceuticals Inc. stock attracts strong analyst attentionJuly 2025 Movers & Weekly High Return Opportunities - Newser
Sector ETF Data Correlates with Strength in Milestone Pharmaceuticals Inc.July 2025 Chart Watch & Stock Market Timing Techniques - beatles.ru
How to build a custom watchlist for Milestone Pharmaceuticals Inc.Earnings Summary Report & Community Driven Trade Alerts - Newser
Milestone Pharmaceuticals Inc. Tests 50 Day MA After Sharp Decline getLinesFromResByArray error: size == 0 - 강소기업뉴스
Is it time to cut losses on Milestone Pharmaceuticals Inc.Market Growth Review & Detailed Earnings Play Strategies - Newser
Will Milestone Pharmaceuticals Inc. price bounce be sustainable2025 Historical Comparison & Long-Term Capital Growth Strategies - Newser
Price action breakdown for Milestone Pharmaceuticals Inc.Insider Selling & Stock Portfolio Risk Management - Newser
Chart based exit strategy for Milestone Pharmaceuticals Inc.Earnings Overview Report & Growth Focused Entry Point Reports - Newser
Does Milestone Pharmaceuticals Inc. show high probability of rebound2025 Year in Review & Long-Term Capital Growth Ideas - Newser
What to expect from Milestone Pharmaceuticals Inc. in the next 30 daysJuly 2025 Patterns & Real-Time Volume Trigger Notifications - Newser
Does Milestone Pharmaceuticals Inc. fit your quant trading modelJuly 2025 Outlook & Short-Term High Return Strategies - Newser
Short interest data insights for Milestone Pharmaceuticals IncTrade Analysis Summary & Comprehensive Market Scan Insights - Newser
How to recover losses in Milestone Pharmaceuticals Inc. stockGold Moves & Risk Managed Investment Signals - Newser
Finanzdaten der Milestone Pharmaceuticals Inc-Aktie (MIST)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):